Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam

Annals of Tropical Medicine and Parasitology

Volumn 97, Issue 6, 2003, Pages 575-580

  Giao, P T ^a,b   De Vries, P J ^a   Hung, L Q ^a,b   Binh, T Q ^a   Nam, N V ^c   Kager, P A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b CHO RAY HOSPITAL   (Viet Nam)

^c Binh Thuan Prov Malaria Station   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; MEFLOQUINE;

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; FOLLOW UP; HUMAN; MALARIA FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME; VERTIGO; VIET NAM;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIMALARIALS; ARTEMISININS; ATOVAQUONE; CHILD; CHLOROGUANIDE; DISEASE OUTBREAKS; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; NAPHTHOQUINONES; PARASITEMIA; PLASMODIUM FALCIPARUM; RECURRENCE; SESQUITERPENES; TREATMENT FAILURE; VIETNAM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0041409805     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349803225001427     Document Type: Article

References (23)

1. Bich, N. N., de Vries, P. J., Van, T. H., Phong, T. H., Hung, L. N., Eggelte, T. A., Anh, T. K. & Kager, P. A. (1996). Efficacy and tolerance of artemisinin in short combination regimens for the treatment of uncomplicated falciparum malaria. American Journal of Tropical Medicine and Hygiene, 55, 438-443.
2. Bustos, D. G., Canfield, C. J., Editha, C. M. & Hutchinson, D. B. (1999). Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines. Journal of Infectious Diseases, 179, 1587-1590.
3. Charoenteeraboon, J., Kamchonwongpaisan, S., Wilairat, P., Vattanaviboon, P. & Yuthavong, Y. (2000). Inactivation of artemisinin by thalassemic erythrocytes. Biochemical Pharmacology, 59, 1337-1344.
4. Denis, M. B., Davis, T. M., Hewitt, S., Incardona, S., Nimol, K., Fandeur, T., Poravuth, Y., Lim, C. & Socheat, D. (2002). Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clinical Infectious Diseases, 35, 1469-1476.
5. Fivelman, Q. L., Butcher, G. A., Adagu, I. S., Warhurst, D. C. & Pasvol, G. (2002). Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malaria Journal, 1, 1.
6. Giao, P. T., Binh, T. Q., Kager, P. A., Long, H. P., Van Thang, N., Van Nam, N. & de Vries, P. J. (2001). Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? American Journal of Tropical Medicine and Hygiene, 65, 690-695.
7. Hudson, A. T., Dickins, M., Ginger, C. D., Gutteridge, W. E., Holdich, T., Hutchison, D. B. A., Pudney, M., Randall, A. W. & Latter, V. S. (1991). 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Under Experimental and Clinical Research, 17, 427-435.
8. Hung, L. Q., de Vries, P. J., Giao, P. T., Nam, N. V., Birth, T. Q., Chong, M. T., Quoc, N. T. T. A., Thanh, T. N., Hung, L. N. & Kager, P. A. (2002). Malaria control: a successful experience in South Vietnam. Bulletin of the World Health Organization, 80, 660-666.
9. Le, H. N., de Vries, P. J., Le, T. D., Bich, L. N., Ho, P. L., Tran, N. H., Nguyen, N. V., Trinh, K. A. & Kager, P. A. (1997). Single dose artemisinin-mefloquine versus mefloquine alone for uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 191-194.
10. Looareesuwan, S., Viravan, C., Webster, H. K., Dennis, E. K., Hutchinson, D. B. & Canfield, C. J. (1996). Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 54, 62-66.
11. Looareesuwan, S., Chulay, J. D., Canfield, C. J. & Hutchinson, D. B. (1999a). Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. American Journal of Tropical Medicine and Hygiene, 60, 533-541.
12. Looareesuwan, S., Wilairatana, P., Chalermarut, K., Rattanapaong, Y., Canfield, C. J. & Hutchinson, D. B. (1999b). Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 60, 526-532.
13. Luxemburger, C., Brockman, A., Silamut, K., Nosten, F., van Vugt, M., Gimenez, F., Chongsuphajaisiddhi, T. & White, N. J. (1998). Two patients with falciparum malaria and poor in vivo responses to artesunate. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 668-669.
14. Radloff, P. D., Philipps, J., Nkeyi, M., Hutchinson, D. & Kremsner, P. G. (1996). Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet, 347, 1511-1514.
15. Schuftan, C. & Cong, L. D. (2001). The successful fight against malaria in Vietnam. Mekong Malaria Forum, 8, 30-35.
16. Srivastava, I. K. & Vaidya, A. B. (1999). A mechanism for the synergistic antimalaria action of atovaquone and proguanil. Antimicrobial Agents and Chemotherapy, 43, 1334-1339.
17. Thanh, N. V., Cowman, A. F., Hipgrave, D., Kim, T. B., Phuc, B. Q., Cong, L. D. & Biggs, B. A. (2001). Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Vietnam. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 513-517.
18. Trung, T. N., Davis, T. M., Hewitt, S., Thuan, L. K., Quang, H. H., Anh, C. V., Thuy, P. T., Thoa, N. T., Tuan, N. T., Hang, N. T. & Giang, L. T. (2001). Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimized dosage regimens. Annals of Tropical Paediatrics, 21, 307-312.
19. Van Vugt, M., Leonardi, E., Phaipun, L., Slight, T., Thway, K. L., McGready, R., Brockman, A., Villegas, L., Looareesuwan, S., White, N. J. & Nosten, F. (2002). Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. Clinical Infectious Diseases, 35, 1498-1504.
20. White, N. J. (1999). Antimalarial drug resistance and combination chemotherapy. Philosophical Transactions of the Royal Society of London, Series B, 354, 739-749.
21. World Health Organization (1998). The Use of Artemisinin and its Derivatives as Anti-malarial Drugs. Report of a Joint CTD/DMP/TDR Informal Consultation. Document WHO/MAL/98.1086. Geneva: WHO.
22. World Health Organization (2002). Report Meeting on Antimalarial Drug Development, Shanghai, China, 16-17 November 2001, Manila, Philippines. Document RS/2001/GE/33(CHN). Geneva: WHO.
23. Yuthavong, Y., Butthep, P., Bunyaratvej, A. & Fucharoen, S. (1989). Decreased sensitivity of artesunate and chloroquine of Plasmodium falciparum infecting hemoglobin H and/or hemoglobin constant spring erythrocytes. Journal of Clinical Investigation, 83, 502-505.